By Immune T cells are continuing to target the spike protein of SARS-CoV-2 variants of concern, although mutations are making some T cells less effective, according to new research.
Immune T cell defense is coping with COVID-19 variants of concern (for now)
Digital transformation conceptual for next generation technology era
Comments